Prognos Health Inc. announced that it will receive $23,999,999.97 in funding on April 10, 2023. The company will issue 70,671,378 series I preferred stock at issue price of $0.3396 per share. The shares are convertible into common shares at original issue price.

The shares are convertible and redeemable. The company will issue securities pursuant to exemption provided under Regulation D. The shares carry participating non-cumulative dividend rate of 8% per annum. The round is raised at a post-money valuation of $36,914,290.

The shares are issued at a par value of $0.001 per share.